Clinical Trial Details

EORTC-58111-CLG

Back to Clinical Trials Database

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010. A randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group

Study documentation

Trial Status Recruiting
Dates Date of activation: 16-Mar-2016
Data management at EORTC No
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 35 - All Groups: 612
Treatment Drug
Mercaptopurine, Tioguanine, Cyclophosphamide, Cytarabine, Daunorubicin, Etoposide, Idarubicin, Ifosfamide, Methotrexate, Mitoxantrone, Prednisolone, Vincristine, Dexamethasone, Epratuzumab, Crisantaspase
Study Staff Pierre Rohrlich (Study Coordinator) , CHU de Nice - Hopital De L'Archet, Nice
Claire Gandilhon (Clinical Trial Assistant) claire.gandilhon (at) eortc.org, EORTC Headquarters, Brussels
Stefan Suciu (Statistician) stefan.suciu (at) eortc.org, EORTC Headquarters, Brussels
Laurens Vinckier (Pharmacovigilance Manager) laurens.vinckier (at) eortc.org, EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) gaetan.deschaetzen (at) eortc.org, EORTC Headquarters, Brussels
Type of cancer Acute Lymphocytic Leukemia
Participating groups EORTC Children's Leukemia Group
Charite Universitaetsmedizin Berlin
Recruiting centers CHC - Clinique de l'Esperance (Saint-Nicolas (montegnee), Belgium)
Centre Hospitalier Regional De La Citadelle (Liege, Belgium)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
Hopital Universitaire Des Enfants Reine Fabiola (Brussels, Belgium)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
Universitair Ziekenhuis Brussel (Brussels, Belgium)
Universitair Ziekenhuis Gent (Gent, Belgium)
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number
EudraCT 2012-000793-30